Investigator contact details should continue to be available after completion of clinical trials Reply

被引：0
|
作者：
Maruani, Annabel [1 ]
Boutron, Isabelle [1 ]
Baron, Gabriel [1 ]
Ravaud, Philippe [1 ]
机构：
[1] Univ Paris 05, AP HP, Sorbonne Paris Cite, Hop Hotel Dieu,Ctr Epidemiol Clin,INSERM,U11, Paris, France
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2014年 / 349卷
关键词：
D O I：
10.1136/bmj.g6641
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 33 条
  • [1] EMAIL REMINDERS AND CLINICALTRIALS.GOV Investigator contact details should continue to be available after completion of clinical trials
    O'Neill, Stephen
    Wigmore, Stephen J.
    Fitzgerald, J. Edward
    Bhangu, Aneel
    Harrison, Ewen M.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [2] Clinical Trials Not Causing Harm With Potential for Realizing Benefit Should Continue
    Jackson, Brian Michael
    [J]. AMERICAN JOURNAL OF BIOETHICS, 2019, 19 (10): : 112 - 114
  • [3] Why Medical Educators Should Continue to Focus on Clinical Outcomes Reply
    Cook, David A.
    West, Colin P.
    [J]. ACADEMIC MEDICINE, 2013, 88 (10) : 1403 - 1403
  • [4] Monitoring clinical trials - Interim data should not be publicly available
    Richards, SM
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7326): : 1424 - 1424
  • [5] Monitoring clinical trials - interim data should be publicly available
    Lilford, RJ
    Braunholtz, D
    Edwards, S
    Stevens, A
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7310): : 441 - 442
  • [6] Endpoints in clinical trials -in view of the clinically available devices and investigator's quality-
    Sawa, Mitsuru
    [J]. 8TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS - ISOPT, 2009, : 81 - 84
  • [7] Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question Reply
    Nathan, Steven D.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (10) : 1251 - 1252
  • [8] In reply: Should we ever stop clinical trials for efficacy?
    Jonathan J. Gamble
    Rudy Bowen
    Lloyd Balbuena
    [J]. Canadian Journal of Anesthesia/Journal canadien d'anesthésie, 2018, 65 : 1267 - 1268
  • [9] In reply: Should we ever stop clinical trials for efficacy?
    Gamble, Jonathan J.
    Bowen, Rudy
    Balbuena, Lloyd
    [J]. CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2018, 65 (11): : 1267 - 1268
  • [10] How should pain be controlled in clinical trials for pancreatic cancer? Reply
    Okusaka, T
    Okada, S
    Ishii, H
    Nose, H
    Nakasuka, H
    Nakayama, H
    Nagahama, H
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1996, 26 (05) : 391 - 391
1234